Skip Nav Destination
Update on treatment recommendations from the Third International Workshop on Waldenström's Macroglobulinemia
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins
Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo
Clinical implication of centrosome amplification in plasma cell neoplasm
Gene expression and angiotropism in primary CNS lymphoma
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma
Issue Archive
May 1 2006
In this Issue
Table of Contents
INSIDE BLOOD
BLOOD WORK
EDITORIALS
PERSPECTIVES
ERRATA
REVIEW ARTICLES
Update on treatment recommendations from the Third International Workshop on Waldenström's Macroglobulinemia
Clinical Trials & Observations
Steven P. Treon,Morie A. Gertz,Meletios Dimopoulos,Athanasios Anagnostopoulos,Joan Blade,Andrew R. Branagan,Ramon Garcia-Sanz,Stephen Johnson,Eva Kimby,Veronique LeBlond,Jean-Paul Fermand,David G. Maloney,Giampaolo Merlini,Pierre Morel,Enrica Morra,Gwen Nichols,Enrique M. Ocio,Roger Owen,Marvin J. Stone
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
Clinical Trials & Observations
Maria Domenica Cappellini,Alan Cohen,Antonio Piga,Mohamed Bejaoui,Silverio Perrotta,Leyla Agaoglu,Yesim Aydinok,Antonis Kattamis,Yurdanur Kilinc,John Porter,Marcello Capra,Renzo Galanello,Slaheddine Fattoum,Guillermo Drelichman,Carmelo Magnano,Monica Verissimo,Miranda Athanassiou-Metaxa,Patricia Giardina,Alexandra Kourakli-Symeonidis,Gritta Janka-Schaub,Thomas Coates,Christiane Vermylen,Nancy Olivieri,Isabelle Thuret,Herbert Opitz,Catherine Ressayre-Djaffer,Peter Marks,Daniele Alberti
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study
Clinical Trials & Observations
Roberto Cairoli,Alessandro Beghini,Giovanni Grillo,Gianpaolo Nadali,Francesca Elice,Carla Barbara Ripamonti,Patrizia Colapietro,Michele Nichelatti,Laura Pezzetti,Monia Lunghi,Antonio Cuneo,Assunta Viola,Felicetto Ferrara,Mario Lazzarino,Francesco Rodeghiero,Giovanni Pizzolo,Lidia Larizza,Enrica Morra
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
Clinical Trials & Observations
Frederic Garban,Michel Attal,Mauricette Michallet,Cyrille Hulin,Jean H. Bourhis,Ibrahim Yakoub-Agha,Thierry Lamy,Gerald Marit,Frederic Maloisel,Christian Berthou,Mamoun Dib,Denis Caillot,Bernard dePrijck,Nicolas Ketterer,Jean-Luc Harousseau,Jean-Jacques Sotto,Philippe Moreau,for the Intergroupe Francophone du Myélome and the Swiss Group for Clinical Cancer Research
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins
Clinical Trials & Observations
Brief Report
Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma
Clinical Trials & Observations
Brief Report
Shigesaburo Miyakoshi,Masahiro Kami,Koichiro Yuji,Tomoko Matsumura,Masaaki Takatoku,Makoto Sasaki,Hiroto Narimatsu,Takeshi Fujii,Masateru Kawabata,Shuichi Taniguchi,Keiya Ozawa,Kazuo Oshimi
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo
Brief Report
Paola Patrignani,Concetta Di Febbo,Stefania Tacconelli,Valeria Moretta,Giovanna Baccante,Maria G. Sciulli,Emanuela Ricciotti,Marta L. Capone,Ivana Antonucci,Maria D. Guglielmi,Liborio Stuppia,Ettore Porreca
IMMUNOBIOLOGY
Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines
Belén Blanco,José A. Pérez-Simón,Luis I. Sánchez-Abarca,Xonia Carvajal-Vergara,Juan Mateos,Belén Vidriales,Natalia López-Holgado,Patricia Maiso,Mercedes Alberca,Eva Villarón,David Schenkein,Atanasio Pandiella,Jesús San Miguel
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)
Sarah J. Richardson,Christine Matthews,Mark A. Catherwood,H. Denis Alexander,B. Sean Carey,Joanna Farrugia,Anne Gardiner,Sarah Mould,David Oscier,J. Adrian Copplestone,Archibald G. Prentice
NEOPLASIA
Clinical implication of centrosome amplification in plasma cell neoplasm
Clinical Trials & Observations
Wee J. Chng,Greg J. Ahmann,Kim Henderson,Rafael Santana-Davila,Philip R. Greipp,Morie A. Gertz,Martha Q. Lacy,Angela Dispenzieri,Shaji Kumar,S. Vincent Rajkumar,John A. Lust,Robert A. Kyle,Steven R. Zeldenrust,Suzanne R. Hayman,Rafael Fonseca
Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders
Francesco Passamonti,Elisa Rumi,Daniela Pietra,Matteo G. Della Porta,Emanuela Boveri,Cristiana Pascutto,Laura Vanelli,Luca Arcaini,Sara Burcheri,Luca Malcovati,Mario Lazzarino,Mario Cazzola
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells
Daniela de Totero,Raffaella Meazza,Simona Zupo,Giovanna Cutrona,Serena Matis,Monica Colombo,Enrico Balleari,Ivana Pierri,Marina Fabbi,Matteo Capaia,Bruno Azzarone,Marco Gobbi,Manlio Ferrarini,Silvano Ferrini
Gene expression and angiotropism in primary CNS lymphoma
Clinical Trials & Observations
James L. Rubenstein,Jane Fridlyand,Arthur Shen,Ken Aldape,David Ginzinger,Tracy Batchelor,Patrick Treseler,Mitchel Berger,Michael McDermott,Michael Prados,Jon Karch,Craig Okada,William Hyun,Seema Parikh,Chris Haqq,Marc Shuman
Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia
Clinical Trials & Observations
Brief Report
Derek L. Stirewalt,Kenneth J. Kopecky,Soheil Meshinchi,Julia H. Engel,Era L. Pogosova-Agadjanyan,Jeremy Linsley,Marilyn L. Slovak,Cheryl L. Willman,Jerald P. Radich
PHAGOCYTES
RED CELLS
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
Clinical Trials & Observations
Caterina Borgna-Pignatti,Maria Domenica Cappellini,Piero De Stefano,Giovanni Carlo Del Vecchio,Gian Luca Forni,Maria Rita Gamberini,Roberta Ghilardi,Antonio Piga,Maria Antonietta Romeo,Huaqing Zhao,Avital Cnaan
Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis
Clinical Trials & Observations
Dudley J. Pennell,Vasili Berdoukas,Markissia Karagiorga,Vasili Ladis,Antonio Piga,Athanassios Aessopos,Efstathios D. Gotsis,Mark A. Tanner,Gill C. Smith,Mark A. Westwood,Beatrix Wonke,Renzo Galanello
Ex vivo perfusion of human spleens maintains clearing and processing functions
Pierre A. Buffet,Geneviève Milon,Valentine Brousse,Jean-Michel Correas,Bertrand Dousset,Anne Couvelard,Reza Kianmanesh,Olivier Farges,Alain Sauvanet,François Paye,Marie-Noëlle Ungeheuer,Catherine Ottone,Huot Khun,Laurence Fiette,Ghislaine Guigon,Michel Huerre,Odile Mercereau-Puijalon,Peter H. David
TRANSFUSION MEDICINE
Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT)
Clinical Trials & Observations
Brief Report
Volker Kiefel,Dirk Bassler,Hartmut Kroll,Bosco Paes,Günter Giers,Juliana Ditomasso,Heidemarie Alber,Monika Berns,Bea Wiebe,Ernst-Markus Quenzel,Jochen Hoch,Andreas Greinacher
TRANSPLANTATION
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL
Anthony G. Brickner,Anne M. Evans,Jeffrey K. Mito,Suzanne M. Xuereb,Xin Feng,Tetsuya Nishida,Liane Fairfull,Robert E. Ferrell,Kenneth A. Foon,Donald F. Hunt,Jeffrey Shabanowitz,Victor H. Engelhard,Stanley R. Riddell,Edus H. Warren
Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD
Fabrizio Carnevale-Schianca,Alessandro Cignetti,Antonio Capaldi,Katiuscia Vitaggio,Antonella Vallario,Alberto Ricchiardi,Elisa Sperti,Renato Ferraris,Marco Gatti,Giovanni Grignani,Delia Rota-Scalabrini,Massimo Geuna,Marco Fizzotti,Dario Sangiolo,Antonino Sottile,Giovanni De Rosa,Anna Rosa Bucci,Giorgio Lambertenghi-Deliliers,Edoardo Benedetti,Richard Nash,Massimo Aglietta
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma
Clinical Trials & Observations
Navneet S. Majhail,Daniel J. Weisdorf,John E. Wagner,Todd E. Defor,Claudio G. Brunstein,Linda J. Burns
CORRESPONDENCE
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals